Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

443.33 -56.86 (-11.37%)
Streaming Delayed Price Updated: 9:47 AM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,038,881
Open 465.56
Bid (Size) 443.32 (1)
Ask (Size) 444.25 (1)
Prev. Close 500.19
Today's Range 442.05 - 467.85
52wk Range 377.85 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Rising Costs Weigh on Vertex Q1 Earnings
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
+9.3%
+9.3%
1 Month
-6.6%
-6.6%
3 Month
-5.7%
-5.7%
6 Month
-6.2%
-6.2%
1 Year
+10.1%
+10.1%

More News

Read More
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Via Benzinga
Earnings Scheduled For May 5, 2025
Via Benzinga
Earnings Outlook For Vertex Pharmaceuticals
Via Benzinga
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss
Via Stocktwits
Topics World Trade
Exposures Tariff
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance
Via Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings
Via StockStory
Vertex Reports First Quarter 2025 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
Via Benzinga
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
Via Benzinga
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
5 Growth Stocks to Buy in May and Go Away
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades'
Via Benzinga
Topics Stocks
Exposures US Equities
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential
Via Chartmill
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
Via The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
Via Talk Markets
Topics ETFs Stocks / Equities
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
Via The Motley Fool
Topics Artificial Intelligence Energy
Exposures Artificial Intelligence Fossil Fuels
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
Via The Motley Fool
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
Via The Motley Fool
Topics Government
Exposures Political

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 443.33
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 05/06/25 09:47 AM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 115.01B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 115B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.